Organization · Venture Capital
The Longevity Fund
The Longevity Fund is a venture capital firm based in San Francisco, focusing on investments in biotechnology and health tech companies that aim to extend healthy human lifespan and address age-related diseases. Founded in 2011, it has a legacy portfolio that includes several notable longevity companies.
Overview
What The Longevity Fund does
What The Longevity Fund is
The Longevity Fund is a venture capital firm based in San Francisco, focusing on investments in biotechnology and health tech companies that aim to extend healthy human lifespan and address age-related diseases. Founded in 2011, it has a legacy portfolio that includes several notable longevity companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find The Longevity Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Longevity Fund as a funder
Investment thesis
The Longevity Fund invests in founder-led companies developing therapeutics for age-related diseases, aiming to extend healthy human lifespan. It believes that mission-oriented entrepreneurs are essential for success in the longevity biotech sector.
Focus narrative
The Longevity Fund primarily invests in the longevity sector, particularly in companies that are developing therapeutics for age-related diseases. The organization emphasizes the importance of founder-driven companies, believing that mission-oriented entrepreneurs are crucial for building successful longevity ventures. The fund supports innovative drug development approaches that challenge traditional biotech norms.
Value beyond capital
The Longevity Fund adds value to its portfolio companies by providing strategic guidance and support tailored to the unique challenges of the longevity biotech sector. The fund emphasizes the importance of founder-driven initiatives and aims to foster innovative approaches to drug development that can lead to significant advancements in treating age-related diseases.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 15
- Recorded notable exits
- Unity Biotechnology, Decibel Therapeutics, Metacrine, Precision BioSciences, and ALX Oncology
Portfolio context
Notable portfolio companies include: Alx Oncology: Focuses on oncology therapeutics. Anagenex: Engages in drug discovery and development. ArdaTx: Works on therapeutics for age-related diseases. Conception Bio: Develops solutions in reproductive health. Deciduous Therapeutics: Focuses on therapies for age-related conditions. Fauna Bio: Explores biological solutions inspired by wildlife. General Proximity: Engages in biotechnology innovations. Gordian Bio: Develops therapies targeting aging. Loyal for Dogs: Focuses on canine health and longevity. Metacrine: Works on metabolic diseases. Navitor Pharma: Develops therapies for metabolic diseases. Precision BioSciences: Engages in gene editing technologies. Reservoir Neuro: Focuses on neurodegenerative diseases. RubeDOLife: Develops solutions for healthy aging. Science XYZ: Engages in scientific innovations. Spring Discovery: Focuses on drug discovery. Unity Biotechnology: Develops therapies to slow aging.
Common questions
What to know about The Longevity Fund
Upseed classifies The Longevity Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.